TERTIARY AMIDES AND METHOD OF USE

WIPO Patent Application WO/2017/177004

A8

Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein G1, G2, G3, L1, L2, and L3 are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by the modulation of lysophosphatidic acid receptor 1. Methods for making the compounds are described. Also described are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.

JP2000098533	NOVEL HALOGEN RADICAL RELEASING AGENT, HEAT-DEVELOPABLE PHOTOGRAPHIC SENSITIVE MATERIAL AND IMAGE FORMING METHOD
WO/2003/082853	NEW COMPOUNDS
WO/1991/015123	SUBSTITUTED CYCLOHEXANEDIONES AND THEIR HERBICIDAL USES

BLACK LAWRENCE A (US)
BUNNELLE WILLIAM H (US)
CHEN DA (CN)
CLAPHAM BRUCE (US)
DEGOEY DAVID A (US)
DENG XIANGJUN (CN)
FU LIQIANG (CN)
HAZELWOOD LISA A (US)
KONG LINGLONG (CN)
LANG QINGYU (CN)
LEE CHIH-HUNG (US)
LI MINGFENG (CN)
LUNDGAARD GRETA L (US)
PATEL MEENA V (US)
TAO RUIHONG (CN)
ZHANG LIN (CN)
ZHANG QINGWEI (US)
ZHENG QIANGANG (CN)
ZHU WEI (CN)

PCT/US2017/026361

November 30, 2017

April 06, 2017

Click for automatic bibliography generation  

ABBVIE INC (US)

C07D213/71; A61K31/337; A61K31/341; A61K31/343; A61K31/357; A61K31/36; A61K31/381; A61K31/437; A61K31/47; A61K31/505; A61K31/517; A61P29/00; A61P35/00; C07C235/46; C07C237/44; C07C321/20; C07D213/30; C07D213/81; C07D215/50; C07D217/26; C07D239/28; C07D239/30; C07D241/52; C07D257/06; C07D305/08; C07D307/20; C07D307/52; C07D307/56; C07D311/58; C07D321/10; C07D498/04; C07F9/38

LU, Yu et al. (US)

View/Download PDF      PDF Help

Previous Patent: EXTRACTION AND COMPARISON OF HYBRID PROGRAM BINARY FEATURES

Next Patent: MULTI-MODAL DRIVING DANGER PREDICTION SYSTEM FOR AUTOMOBILES